Deep Intelligent Pharma Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 100

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $78.1M

  • Investors
  • 12

Deep Intelligent Pharma General Information

Description

Developer of artificial intelligence-based drug discovery and pharmaceutical research software designed to support data-driven decision-making in life science. The company applies deep learning and natural language processing to extract, normalize, and analyze biomedical and pharmaceutical data from diverse structured and unstructured sources, enabling pharmaceutical companies, biotechnology firms, and research institutions to reduce manual information processing, prioritize R&D opportunities, and improve the efficiency and consistency of discovery and development activities.

Contact Information

Website
www.dip-ai.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3 Temasek Avenue
  • Suite 21-00, Centennial Tower
  • Singapore
  • Singapore
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 3 Temasek Avenue
  • Suite 21-00, Centennial Tower
  • Singapore
  • Singapore

Deep Intelligent Pharma Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Deep Intelligent Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 02-Feb-2026 $78.1M Completed Generating Revenue
7. Later Stage VC (Series D) 11-Dec-2025 Completed Generating Revenue
6. Early Stage VC (Series B1) 01-Dec-2019 Completed Generating Revenue
5. Early Stage VC (Series B) 09-Oct-2018 Completed Generating Revenue
4. Early Stage VC (Series A) 01-May-2018 Completed Generating Revenue
3. Early Stage VC 01-Dec-2017 Completed Startup
2. Seed Round 23-Nov-2017 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Deep Intelligent Pharma’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Deep Intelligent Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Deep Intelligent Pharma Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Jinyi Capital Venture Capital Minority
Kaitai Capital Venture Capital Minority
NewDing Capital Venture Capital Minority
Trustar Capital PE/Buyout Minority
Xinchen Capital Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Deep Intelligent Pharma Investments (2)

Deep Intelligent Pharma’s most recent deal was a Later Stage VC with iMBIORAY for . The deal was made on 05-Feb-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
iMBIORAY 05-Feb-2026 Later Stage VC Drug Discovery
Jinkebo Biotechnology 28-Nov-2025 Early Stage VC Biotechnology
To view Deep Intelligent Pharma’s complete investments history, request access »

Deep Intelligent Pharma FAQs

  • When was Deep Intelligent Pharma founded?

    Deep Intelligent Pharma was founded in 2017.

  • Where is Deep Intelligent Pharma headquartered?

    Deep Intelligent Pharma is headquartered in Singapore, Singapore.

  • What is the size of Deep Intelligent Pharma?

    Deep Intelligent Pharma has 100 total employees.

  • What industry is Deep Intelligent Pharma in?

    Deep Intelligent Pharma’s primary industry is Discovery Tools (Healthcare).

  • Is Deep Intelligent Pharma a private or public company?

    Deep Intelligent Pharma is a Private company.

  • What is Deep Intelligent Pharma’s current revenue?

    The current revenue for Deep Intelligent Pharma is .

  • How much funding has Deep Intelligent Pharma raised over time?

    Deep Intelligent Pharma has raised $143M.

  • Who are Deep Intelligent Pharma’s investors?

    Jinyi Capital, Kaitai Capital, NewDing Capital, Trustar Capital, and Xinchen Capital are 5 of 12 investors who have invested in Deep Intelligent Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process